Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Apollo pressure-activated safety lancets 2.4mm/23gauge (Apollo Medical Technologies Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Fenticonazole 2% vaginal cream 30 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Lancets sterile single use 2.4mm/23gauge 100 lancet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic NuTRIflex Lipid plus without Electrolytes infusion 2.5litre bags 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NuTRIflex Lipid plus without Electrolytes infusion 1.875litre bags (B.Braun Medical Ltd) 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Nutriflex Omega Special infusion 2.5litre bags (B.Braun Medical Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic NuTRIflex Lipid plus without Electrolytes infusion 1.875litre bags 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NuTRIflex Lipid plus without Electrolytes emulsion for infusion 1.25litre bags (B.Braun Medical Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) 28 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NuTRIflex Lipid plus without Electrolytes infusion 1.25litre bags (B.Braun Medical Ltd) 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Gynoxin 600mg vaginal capsules (Recordati Pharmaceuticals Ltd) 1 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic NuTRIflex Lipid plus without Electrolytes infusion 1.25litre bags 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NuTRIflex Lipid plus without Electrolytes infusion 2.5litre bags (B.Braun Medical Ltd) 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic Nutriflex Omega Special infusion 2.5litre bags 1 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Gynoxin 600mg vaginal capsules (Recordati Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Nutriflex Omega Special infusion 2.5litre bags (B.Braun Medical Ltd) 5 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic NuTRIflex Lipid plus without Electrolytes infusion 1.25litre bags 5 bag |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Chlorhexidine gluconate 5% solution |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ceritinib 150mg capsules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alemtuzumab 30mg/1ml solution for injection vials |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ceritinib 150mg capsules 150 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Hibitane 5% concentrate solution (Regent Medical Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Zykadia 150mg capsules (Novartis Pharmaceuticals UK Ltd) 150 capsule 3 x (5 x 10 capsules) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Chlorhexidine gluconate 5% solution 5 litre |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
MabCampath Concentrate 30mg/1ml solution for injection vials (Schering Health Care Ltd) 3 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Hibitane 5% concentrate solution (Regent Medical Ltd) 5 litre |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alemtuzumab 30mg/1ml solution for injection vials 3 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Zykadia 150mg capsules (Novartis Pharmaceuticals UK Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
MabCampath Concentrate 30mg/1ml solution for injection vials (Schering Health Care Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
HiBiTane Plus 5% concentrate solution (Molnlycke Health Care Ltd) 5000 ml |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
HiBiTane Plus 5% concentrate solution (Molnlycke Health Care Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Senna fruit 12.4% / Ispaghula 54.2% granules |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Asparaginase 10,000unit powder for solution for infusion vials |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous powder |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Tinaderm Plus 1% powder (Schering-Plough Ltd) 50 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Spectrila 10,000unit powder for concentrate for solution for infusion vials (medac UK) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Asparaginase 10,000unit powder for solution for infusion vials 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Tolnaftate 1% powder 50 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Spectrila 10,000unit powder for concentrate for solution for infusion vials (medac UK) 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Tolnaftate 1% powder 75 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Scholl Athlete's Foot 1% powder (SSL International Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Scholl Athlete's Foot 1% powder (SSL International Plc) 75 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Tinaderm Plus 1% powder (Schering-Plough Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Colecalciferol 14,400units/ml oral drops sugar free |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
High Purity Factor IX 1,500unit powder and solvent for solution for injection vials |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
AlphaNine 1,500unit powder and solvent for solution for injection vials (Grifols UK Ltd) 1 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
High Purity Factor IX 1,500unit powder and solvent for solution for injection vials 1 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Colecalciferol 14,400units/ml oral drops sugar free 12.5 ml |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
AlphaNine 1,500unit powder and solvent for solution for injection vials (Grifols UK Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Sapvit-D3 14,400units/ml oral drops (Stirling Anglian Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Sapvit-D3 14,400units/ml oral drops (Stirling Anglian Pharmaceuticals Ltd) 12.5 ml |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ethinylestradiol 10 microgram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 15mg soluble tablets sugar free |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic Triple Care barrier cream |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 20mg soluble tablets sugar free |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 5mg soluble tablets sugar free |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 10mg soluble tablets sugar free |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely flucytosine 500 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ethinylestradiol 50 microgram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 300micrograms/24hours patches |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic Alzhok soluble tablets treatment initiation pack sugar free |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely telbivudine 600 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic Triple Care Extra Protective barrier cream |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 10microgram tablets (Celltech Pharmaceuticals Ltd) 21 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Trasylol 140mg/100ml solution for injection vials (Bayer Plc) 1 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 10microgram tablets (Celltech Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 300micrograms/24hours patches 8 patch |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 50microgram tablets (Unichem Plc) 21 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 8 patch |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 15mg soluble tablets sugar free 7 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 20mg soluble tablets sugar free 7 tablet |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 50microgram tablets (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 50microgram tablets (Celltech Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Triple Care Extra Protective barrier cream (Smith & Nephew Healthcare Ltd) 92 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (Necessity Supplies Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Triple Care barrier cream (Smith & Nephew Healthcare Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 15mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Trasylol 140mg/100ml solution for injection vials (Bayer Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 20mg soluble tablets sugar free 28 tablet |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 50microgram tablets 21 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 10microgram tablets (Unichem Plc) 21 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Memantine 10mg soluble tablets sugar free 7 tablet |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) 8 patch |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (Lexon (UK) Ltd) 8 patch |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok soluble tablets treatment initiation pack (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 1x(7tabs+7tabs+7tabs+7tabs) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok soluble tablets treatment initiation pack (Glenmark Pharmaceuticals Europe Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Triple Care barrier cream (Smith & Nephew Healthcare Ltd) 78 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Ethinylestradiol 10microgram tablets 21 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Intrinsa 300micrograms/24hours transdermal patches (Lexon (UK) Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Sebivo 600mg tablets (Novartis Pharmaceuticals UK Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Generic Triple Care barrier cream 78 gram |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|